Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study

OBJECTIVES: Transarterial chemoembolization (TACE) or sorafenib may prolong survival in patients with unresectable hepatocellular carcinoma (HCC); however, whether their combination prolongs survival than TACE alone remains controversial. We aimed to compare the overall survival (OS) of patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Tzu-Rong, Wu, Ta-Wei, Wu, Chao-Chuan, Chang, Sou-Yi, Chan, Cheng-Yi, Hsu, Ching-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020249/
https://www.ncbi.nlm.nih.gov/pubmed/35465280
http://dx.doi.org/10.4103/tcmj.tcmj_84_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020249/
https://www.ncbi.nlm.nih.gov/pubmed/35465280
http://dx.doi.org/10.4103/tcmj.tcmj_84_21

Ejemplares similares